- Home
- GBR vs TRIB Comparison
GBR vs TRIB Comparison
Compare GBR & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBR
- TRIB
- Stock Information
- Founded
- GBR 1978
- TRIB 1992
- Country
- GBR United States
- TRIB Ireland
- Employees
- GBR N/A
- TRIB N/A
- Industry
- GBR Oil & Gas Production
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GBR Energy
- TRIB Health Care
- Exchange
- GBR Nasdaq
- TRIB Nasdaq
- Market Cap
- GBR 5.2M
- TRIB 5.4M
- IPO Year
- GBR N/A
- TRIB N/A
- Fundamental
- Price
- GBR $0.86
- TRIB $0.99
- Analyst Decision
- GBR
- TRIB
- Analyst Count
- GBR 0
- TRIB 0
- Target Price
- GBR N/A
- TRIB N/A
- AVG Volume (30 Days)
- GBR 35.5K
- TRIB 129.2K
- Earning Date
- GBR 11-12-2025
- TRIB 11-14-2025
- Dividend Yield
- GBR N/A
- TRIB N/A
- EPS Growth
- GBR N/A
- TRIB N/A
- EPS
- GBR N/A
- TRIB N/A
- Revenue
- GBR $151,000.00
- TRIB $61,555,000.00
- Revenue This Year
- GBR N/A
- TRIB $13.51
- Revenue Next Year
- GBR N/A
- TRIB $13.14
- P/E Ratio
- GBR N/A
- TRIB N/A
- Revenue Growth
- GBR 4.14
- TRIB 8.31
- 52 Week Low
- GBR $0.67
- TRIB $0.48
- 52 Week High
- GBR $1.78
- TRIB $3.44
- Technical
- Relative Strength Index (RSI)
- GBR 33.96
- TRIB 40.27
- Support Level
- GBR $0.91
- TRIB $1.00
- Resistance Level
- GBR $0.98
- TRIB $1.10
- Average True Range (ATR)
- GBR 0.04
- TRIB 0.07
- MACD
- GBR -0.02
- TRIB -0.00
- Stochastic Oscillator
- GBR 0.00
- TRIB 14.20
About GBR New Concept Energy Inc
New Concept Energy Inc is a United States-based company engaged in Real Estate Operations. It intends to continue to operate and or sell its West Virginia property. It provides advisory and management services for an independent West Virginia oil and gas company. The Company seeks to establish or acquire new business operations. It operates in one segment, which is real estate rental.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.